166 related articles for article (PubMed ID: 17890456)
41. 'ACOPP' chemotherapy for older and less fit patients with Hodgkin lymphoma-A multicentre, retrospective study.
Wilson MR; Haynes E; Parsons K; Hopkins D; Robertson E; Ferguson G; Quinn D; Murray J; Osborne W; Leach M; McKay P
Br J Haematol; 2023 Aug; 202(4):796-800. PubMed ID: 37357380
[TBL] [Abstract][Full Text] [Related]
42. Current clinical trials for the treatment of advanced-stage Hodgkin's disease: BEACOPP.
Franklin J; Diehl V
Ann Oncol; 2002; 13 Suppl 1():98-101. PubMed ID: 12078913
[TBL] [Abstract][Full Text] [Related]
43. ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.
Mondello P; Musolino C; Dogliotti I; Bohn JP; Cavallo F; Ferrero S; Botto B; Cerchione C; Nappi D; De Lorenzo S; Martinelli G; Wolf D; Schmitt C; Loseto G; Cuzzocrea S; Willenbacher W; Mian M; Straus DJ
Am J Hematol; 2020 Sep; 95(9):1030-1037. PubMed ID: 32419224
[TBL] [Abstract][Full Text] [Related]
44. The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphoma.
Gobbi PG; Rosti V; Valentino F; Bonetti E; Merli F; Stelitano C; Dondi A; Quarta G; Falorio S; Federico M
Clin Lymphoma Myeloma; 2009 Dec; 9(6):425-9. PubMed ID: 19951881
[TBL] [Abstract][Full Text] [Related]
45. Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP.
Albano D; Patti C; La Grutta L; Grassedonio E; Mulè A; Brancatelli G; Lagalla R; Midiri M; Galia M
Eur Radiol; 2017 May; 27(5):2129-2136. PubMed ID: 27519911
[TBL] [Abstract][Full Text] [Related]
46. Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
Carde P; Cavalli F; Diehl V; Franklin J
Hematol J; 2000; 1(4):282-90. PubMed ID: 11920203
[No Abstract] [Full Text] [Related]
47. Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Merli F; Luminari S; Gobbi PG; Cascavilla N; Mammi C; Ilariucci F; Stelitano C; Musso M; Baldini L; Galimberti S; Angrilli F; Polimeno G; Scalzulli PR; Ferrari A; Marcheselli L; Federico M
J Clin Oncol; 2016 Apr; 34(11):1175-81. PubMed ID: 26712220
[TBL] [Abstract][Full Text] [Related]
48. The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
Gerres L; Brämswig JH; Schlegel W; Jürgens H; Schellong G
Cancer; 1998 Nov; 83(10):2217-22. PubMed ID: 9827728
[TBL] [Abstract][Full Text] [Related]
49. Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom.
Bröckelmann PJ; McMullen S; Wilson JB; Mueller K; Goring S; Stamatoullas A; Zagadailov E; Gautam A; Huebner D; Dalal M; Illidge T
Br J Haematol; 2019 Jan; 184(2):202-214. PubMed ID: 30239982
[TBL] [Abstract][Full Text] [Related]
50. Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704.
Kelly KM; Hutchinson RJ; Sposto R; Weiner MA; Lones MA; Perkins SL; Massey V;
Ann Oncol; 2002; 13 Suppl 1():107-11. PubMed ID: 12078889
[TBL] [Abstract][Full Text] [Related]
51. Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial.
Gallamini A; Tarella C; Viviani S; Rossi A; Patti C; Mulé A; Picardi M; Romano A; Cantonetti M; La Nasa G; Trentin L; Bolis S; Rapezzi D; Battistini R; Gottardi D; Gavarotti P; Corradini P; Cimminiello M; Schiavotto C; Parvis G; Zanotti R; Gini G; Ferreri AJM; Viero P; Miglino M; Billio A; Avigdor A; Biggi A; Fallanca F; Ficola U; Gregianin M; Chiaravalloti A; Prosperini G; Bergesio F; Chauvie S; Pavoni C; Gianni AM; Rambaldi A
J Clin Oncol; 2018 Feb; 36(5):454-462. PubMed ID: 29360414
[TBL] [Abstract][Full Text] [Related]
52. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
Eich HT; Diehl V; Görgen H; Pabst T; Markova J; Debus J; Ho A; Dörken B; Rank A; Grosu AL; Wiegel T; Karstens JH; Greil R; Willich N; Schmidberger H; Döhner H; Borchmann P; Müller-Hermelink HK; Müller RP; Engert A
J Clin Oncol; 2010 Sep; 28(27):4199-206. PubMed ID: 20713848
[TBL] [Abstract][Full Text] [Related]
53. Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.
Vijenthira A; Chan K; Cheung MC; Prica A
Lancet Haematol; 2020 Feb; 7(2):e146-e156. PubMed ID: 31948928
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of acute and early cardiotoxicity in survivors of Hodgkin's disease treated with ABVD or BEACOPP regimens.
Elbl L; Vasova I; Kral Z; Tomaskova I; Smardova L; Wagnerova B; Jedlicka F; Vorlicek J
J Chemother; 2006 Apr; 18(2):199-208. PubMed ID: 16736890
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of ovarian reserve before and after chemotherapy.
Berjeb KK; Debbabi L; Braham M; Zemni Z; Chtourou S; Hannachi H; Hamdoun M; Ayadi M; Kacem K; Zhioua F; Fadhlaoui A; Bahri O; Chakroun N
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102035. PubMed ID: 33307239
[TBL] [Abstract][Full Text] [Related]
56. Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
Sasse S; Goergen H; Plütschow A; Böll B; Eichenauer DA; Fuchs M; Behringer K; Zijlstra JM; Greil R; Markova J; Topp MS; Meissner J; Neubauer A; Baues C; Engert A; Borchmann P; von Tresckow B
J Clin Oncol; 2018 Sep; 36(25):2603-2611. PubMed ID: 29989855
[TBL] [Abstract][Full Text] [Related]
57. Treatment of intermediate and advanced stage Hodgkin's disease with modified baseline BEACOPP regimen: a Hellenic Co-operative Oncology Group Study.
Economopoulos T; Fountzilas G; Dimopoulos MA; Papageorgiou S; Xiros N; Kalantzis D; Dervenoulas J; Raptis S
Eur J Haematol; 2003 Oct; 71(4):257-62. PubMed ID: 12950234
[TBL] [Abstract][Full Text] [Related]
58. [Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
Soriano Guillén L; Muñoz Calvo MT; Pozo Román J; Contra Gómez T; Buño Soto M; Argente Oliver J
An Esp Pediatr; 2000 Oct; 53(4):318-23. PubMed ID: 11083980
[TBL] [Abstract][Full Text] [Related]
59. Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma.
Niitsu N; Okamoto M; Tomita N; Aoki S; Tamaru J; Miura I; Hirano M
Leuk Lymphoma; 2006 Sep; 47(9):1908-14. PubMed ID: 17065005
[TBL] [Abstract][Full Text] [Related]
60. BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group.
Diehl V; Sieber M; Rüffer U; Lathan B; Hasenclever D; Pfreundschuh M; Loeffler M; Lieberz D; Koch P; Adler M; Tesch H
Ann Oncol; 1997 Feb; 8(2):143-8. PubMed ID: 9093722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
